Terms: = Brain cancer AND CDK6, MGC59692, 1021, Q00534, ENSG00000105810, PLSTIRE AND Treatment
58 results:
1. DMC-siERCC2 hybrid nanoparticle enhances TRAIL sensitivity by inducing cell cycle arrest for glioblastoma treatment.
Song M; Wang T; Liu T; Lei T; Teng X; Peng Q; Zhu Q; Chen F; Zhao G; Li K; Qi L
Biomed Pharmacother; 2024 May; 174():116470. PubMed ID: 38565061
[TBL] [Abstract] [Full Text] [Related]
2. A Potential Anti-Glioblastoma Compound LH20 Induces Apoptosis and Arrest of Human Glioblastoma Cells via CDK4/6 Inhibition.
Wang Y; Li Y; Liu D; Zheng D; Li X; Li C; Huang C; Wang Y; Wang X; Li Q; Xu J
Molecules; 2023 Jun; 28(13):. PubMed ID: 37446710
[TBL] [Abstract] [Full Text] [Related]
3. Clinical features and therapeutic outcomes of GH/TSH cosecreting pituitary adenomas: experience of a single pituitary center.
Yu N; Duan L; Hu F; Yang S; Liu J; Chen M; Yao Y; Deng K; Feng F; Lian X; Mao X; Zhu H
Front Endocrinol (Lausanne); 2023; 14():1197244. PubMed ID: 37324275
[TBL] [Abstract] [Full Text] [Related]
4. Exosomal RNAs in the development and treatment of pituitary adenomas.
Chang M; Jiang S; Guo X; Gao J; Liu P; Bao X; Feng M; Wang R
Front Endocrinol (Lausanne); 2023; 14():1142494. PubMed ID: 36875488
[TBL] [Abstract] [Full Text] [Related]
5. Evaluating the impact of early identification of asymptomatic brain metastases in metastatic renal cell carcinoma.
Parmar A; Ghosh S; Sahgal A; Lalani AA; Hansen AR; Reaume MN; Wood L; Basappa NS; Heng DYC; Graham J; Kollmannsberger C; Soulières D; Breau RH; Tanguay S; Kapoor A; Pouliot F; Bjarnason GA
Cancer Rep (Hoboken); 2023 Mar; 6(3):e1763. PubMed ID: 36517084
[TBL] [Abstract] [Full Text] [Related]
6. Integrated proteogenomic characterization across major histological types of pituitary neuroendocrine tumors.
Zhang F; Zhang Q; Zhu J; Yao B; Ma C; Qiao N; He S; Ye Z; Wang Y; Han R; Feng J; Wang Y; Qin Z; Ma Z; Li K; Zhang Y; Tian S; Chen Z; Tan S; Wu Y; Ran P; Wang Y; Ding C; Zhao Y
Cell Res; 2022 Dec; 32(12):1047-1067. PubMed ID: 36307579
[TBL] [Abstract] [Full Text] [Related]
7. Multi-institutional study of the frequency, genomic landscape, and outcome of IDH-mutant glioma in pediatrics.
Yeo KK; Alexandrescu S; Cotter JA; Vogelzang J; Bhave V; Li MM; Ji J; Benhamida JK; Rosenblum MK; Bale TA; Bouvier N; Kaneva K; Rosenberg T; Lim-Fat MJ; Ghosh H; Martinez M; Aguilera D; Smith A; Goldman S; Diamond EL; Gavrilovic I; MacDonald TJ; Wood MD; Nazemi KJ; Truong A; Cluster A; Ligon KL; Cole K; Bi WL; Margol AS; Karajannis MA; Wright KD
Neuro Oncol; 2023 Jan; 25(1):199-210. PubMed ID: 35604410
[TBL] [Abstract] [Full Text] [Related]
8. Genetic Markers as Predictors for Response to treatment and Possible Therapeutic Targets in Medulloblastoma.
Pérez-Pineda PL; Ortiz-Butrón R; Pérez-De Marcos JC; Hernández-Regino LM; Zapata-Tarrés MM; Torres-Espíndola LM
CNS Neurol Disord Drug Targets; 2023; 22(5):634-642. PubMed ID: 35579144
[TBL] [Abstract] [Full Text] [Related]
9. Syringic Acid Suppressed Proliferation, Invasion, and Migration via Inhibition of Matrix Metalloproteinases Expression on Glioblastoma Cells by Promoting Apoptosis.
Li D; Luo D; Hu S; Zhao H; Peng B
Curr Pharm Biotechnol; 2023; 24(2):310-316. PubMed ID: 35570553
[TBL] [Abstract] [Full Text] [Related]
10. Molecular Stratification of Medulloblastoma: Clinical Outcomes and Therapeutic Interventions.
Sursal T; Ronecker JS; Dicpinigaitis AJ; Mohan AL; Tobias ME; Gandhi CD; Jhanwar-Uniyal M
Anticancer Res; 2022 May; 42(5):2225-2239. PubMed ID: 35489737
[TBL] [Abstract] [Full Text] [Related]
11. Hydrocephalus Associated with Posterior Fossa Tumors: How to Manage Effectively?
Muthukumar N
Neurol India; 2021; 69(Supplement):S342-S349. PubMed ID: 35102986
[TBL] [Abstract] [Full Text] [Related]
12. The RNA-Binding Protein Musashi1 Regulates a Network of Cell Cycle Genes in Group 4 Medulloblastoma.
Baroni M; Guardia GDA; Lei X; Kosti A; Qiao M; Landry T; Mau K; Galante PAF; Penalva LOF
Cells; 2021 Dec; 11(1):. PubMed ID: 35011618
[TBL] [Abstract] [Full Text] [Related]
13. Epigenome-wide association study of alcohol consumption in N = 8161 individuals and relevance to alcohol use disorder pathophysiology: identification of the cystine/glutamate transporter SLC7A11 as a top target.
Lohoff FW; Clarke TK; Kaminsky ZA; Walker RM; Bermingham ML; Jung J; Morris SW; Rosoff D; Campbell A; Barbu M; Charlet K; Adams M; Lee J; Howard DM; O'Connell EM; Whalley H; Porteous DJ; McIntosh AM; Evans KL
Mol Psychiatry; 2022 Mar; 27(3):1754-1764. PubMed ID: 34857913
[TBL] [Abstract] [Full Text] [Related]
14. A Preclinical Investigation of GBM-N019 as a Potential Inhibitor of Glioblastoma via Exosomal mTOR/cdk6/STAT3 Signaling.
Wu ATH; Huang HS; Wen YT; Lawal B; Mokgautsi N; Huynh TT; Hsiao M; Wei L
Cells; 2021 Sep; 10(9):. PubMed ID: 34572040
[TBL] [Abstract] [Full Text] [Related]
15. Systems pharmacogenomics identifies novel targets and clinically actionable therapeutics for medulloblastoma.
Genovesi LA; Millar A; Tolson E; Singleton M; Hassall E; Kojic M; Brighi C; Girard E; Andradas C; Kuchibhotla M; Bhuva DD; Endersby R; Gottardo NG; Bernard A; Adolphe C; Olson JM; Taylor MD; Davis MJ; Wainwright BJ
Genome Med; 2021 Jun; 13(1):103. PubMed ID: 34154646
[TBL] [Abstract] [Full Text] [Related]
16. Convexity Meningiomas in Patients with Neurofibromatosis Type 2: Long-Term Outcomes After Gamma Knife Radiosurgery.
Ruiz-Garcia H; Trifiletti DM; Mohammed N; Hung YC; Xu Z; Chytka T; Liscak R; Tripathi M; Arsanious D; Cifarelli CP; Caceres MP; Mathieu D; Speckter H; Lekovic GP; Mehta GU; Sheehan JP
World Neurosurg; 2021 Feb; 146():e678-e684. PubMed ID: 33152493
[TBL] [Abstract] [Full Text] [Related]
17. Physiologically Based Pharmacokinetic Modeling of Central Nervous System Pharmacokinetics of CDK4/6 Inhibitors to Guide Selection of Drug and Dosing Regimen for brain cancer treatment.
Li J; Jiang J; Wu J; Bao X; Sanai N
Clin Pharmacol Ther; 2021 Feb; 109(2):494-506. PubMed ID: 32799335
[TBL] [Abstract] [Full Text] [Related]
18. Evaluating anti-tumor activity of palbociclib plus radiation in anaplastic and radiation-induced meningiomas: pre-clinical investigations.
Das A; Alshareef M; Martinez Santos JL; Porto GBF; McDonald DG; Infinger LK; Vandergrift WA; Lindhorst SM; Varma AK; Patel SJ; Cachia D
Clin Transl Oncol; 2020 Nov; 22(11):2017-2025. PubMed ID: 32253706
[TBL] [Abstract] [Full Text] [Related]
19. Dissociation of Pubertal Development Abnormality and Gonadal Dysfunction in Childhood cancer Survivors.
Yu B; Fritz R; Vega M; Merino M
J Adolesc Young Adult Oncol; 2020 Aug; 9(4):490-495. PubMed ID: 32186962
[No Abstract] [Full Text] [Related]
20. SPH3643: A novel cyclin-dependent kinase 4/6 inhibitor with good anticancer efficacy and strong blood-brain barrier permeability.
Liao X; Hong Y; Mao Y; Chen N; Wang Q; Wang Z; Zhang L; Wang L; Shi C; Shi W; Ge H; Li A; Li X; Xia G; Liu Y
Cancer Sci; 2020 May; 111(5):1761-1773. PubMed ID: 32103527
[TBL] [Abstract] [Full Text] [Related]
[Next]
